About this course
This course explores the genomic revolution’s impact on medical science, clinical diagnoses, and cutting-edge treatments, illustrating both where the genomic ideology has triumphed and where it has failed. We dive into diagnostic sequencing technologies, preimplantation, prenatal and preventive medicine, and explore current gene therapies including the promise of genome editing, as well as, debate the multifaceted ethical implications of the genomic revolution.
Syllabus
Pre-requisites
One year of biology and one year of chemistry at university level.
Faculty
Ulrik Kristoffer Stoltze
FacultyPhD (2023) & M.D. (University of Copenhagen, 2017), leader of a clinic for childhood cancer surveillance (2021-) and affiliated scientist at Broad Institute of MIT and Harvard (2023-). Former Clinical Genetics resident (Rigshospitalet, 2018-19), General Practice resident (Søborg, 2018), Surgery resident (Herlev Hospital, 2017). POST-fellow at St. Jude Children’s Research Hospital (Memphis, 2016). Active in Genomics research since 2015 with several publications in genetics and bioethics with a focus on childhood cancer. He is conducting one of Denmark’s largest genomics studies offering whole-genome sequencing to any cancer patient under 18 years old. Teaching at DIS since 2017. Currently on leave.